利索-全球专利检索

  1. 登录
  2. 注册
发明授权
CN101084998B 一种复方丹参冻干粉针剂 失效 - 权利终止

一种复方丹参冻干粉针剂
摘要：
本发明药物是提供一种复方丹参冻干粉针剂。本发明是由丹参、三七、冰片为药物组成，丹参、三七经过提取，得丹参提取物、三七提取物；冰片用适量乙醇溶解，制成的冻干粉针剂。本发明药物更加适合危、重、急症的临床需要。其中三七以人参皂苷Rg1(C27H32O16)、人参皂苷Rb1、三七皂苷R1的总量计，含量为12.5～50.0mg/g冻干粉固形物；丹参以丹参素(C9H10O5)计，含量为2.5～15.5mg/g冻干粉固形物；丹参以丹酚酸B(C36H30O16)计，含量为12.5～75.0mg/g冻干粉固形物；冰片以右旋龙脑(C10H18O)计，含量为12.5～62.5mg/g冻干粉固形物。
摘要（英）：

The present invention provides a compound red sage root freeze dried powder injection which comprises root of red rooted saliva, notoginseng, baras camphor through extracting root of red rooted saliva, notoginseng to obtain red sage root extract, pseudo-ginseng extract, finally dissolving baras camphor with right amount of ethanol. Calculated by the total amount of ginseng saponin Rg1 (C27H32O16), ginseng saponin Rb1, the content of notoginseng saponin R1 is 12.5-50.0mg/g of freeze-dried powder solid. Calculated by Danshensu (C9H10O5), the content of notoginseng is 2.5-15.5mg/g freeze-dried powder solid. Calculated by salvianolic acid B (C36H30O16), the content of salvia miltiorrhizae is 12.5-75.0mg/g of freeze-dried powder solid. Calculated by D-borneol (C10H180), the content of baras camphor is12.5-62.5mg/g of freeze-dried powder solid.

公开/授权文献
0/0